These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 12886712

  • 1. Leprosy in a Mexican immigrant.
    Baker B, Evans M, DeCastro F, Schosser R.
    J Ky Med Assoc; 2003 Jul; 101(7):289-94. PubMed ID: 12886712
    [Abstract] [Full Text] [Related]

  • 2. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK, Girdhar A, Natrajan M, Kumar A, Girdhar BK.
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [Abstract] [Full Text] [Related]

  • 3. Leprosy: not always an easy diagnosis and often a management challenge.
    Manifold R, Marshman G.
    Australas J Dermatol; 2009 Feb; 50(1):36-40. PubMed ID: 19178490
    [Abstract] [Full Text] [Related]

  • 4. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S, Reddy R.
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract] [Full Text] [Related]

  • 5. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS, Scolyer RA, Barnetson RS.
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
    Katoch K, Natarajan M, Bagga A, Katoch VM.
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):248-54. PubMed ID: 2071982
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S, Hajra SK, Mukerjee A, Saha B, Majumdar V, Chattapadhya D, Saha K.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [Abstract] [Full Text] [Related]

  • 18. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy.
    Kumar S, Mehta H, Aggarwal D, Chatterjee D, Narang T, Dogra S.
    Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of leprosy.
    Kar HK, Gupta R.
    Clin Dermatol; 2015 Apr; 33(1):55-65. PubMed ID: 25432811
    [Abstract] [Full Text] [Related]

  • 20. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T, Kaur I, Kumar B, Radotra BD, Dogra S.
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.